Enanta Pharmaceuticals(CH:9EP)
CH:9EP
Enanta Pharmaceuticals earnings date
Enanta Pharmaceuticals (9EP) Q4 2023 Earnings Report
0 Followers
CH:9EP Q4 2023 EPS Results
- Actual EPS
- -CHF 1.12
- Consensus EPS
- -CHF 1.79
- Beat/Miss
- Beat by +CHF 0.67
- One Year Ago EPS
- -CHF 1.07
CH:9EP Q4 2023 Revenue Results
- Actual Revenue
- CHF 15.97M
- Expected Revenue
- CHF 14.76M
- Beat/Miss
- Beat by +CHF 1.22M
- YoY Revenue Growth
- -6.82%
Earnings Announcement Details
- Quarter
- Q4 2023
- Date
- 11/20/2023
- Time
- After Close
- Conference Call
- Monday, November 20, 2023
CH:9EP Upcoming Earnings
Enanta Pharmaceuticals's next earnings date is estimated for February 8, 2027, based on past reporting schedules.
Q4 2023 Earnings Call Audio
CH:9EP Q4 2023 Earnings Call
0:00 / 0:00
Q4 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:9EP Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 08, 2027 | 2027 (Q1) | -0.53- | -0.35 | ― | ― |
| Nov 16, 2026 | 2026 (Q4) | -0.61-0.68 | -0.73 | 6.90% (+0.05) | |
| Aug 10, 2026 | 2026 (Q3) | -0.43-0.57 | -0.72 | 21.18% (+0.15) | |
| May 11, 2026 | 2026 (Q2) | -0.41-0.38 | -0.89 | 57.55% (+0.51) | |
| Feb 09, 2026 | 2026 (Q1) | -0.65-0.35 | -0.89 | 60.00% (+0.53) | |
| Nov 17, 2025 | 2025 (Q4) | -0.86-0.73 | -1.15 | 36.03% (+0.41) | |
| Aug 11, 2025 | 2025 (Q3) | -0.76-0.72 | -0.9 | 20.56% (+0.19) | |
| May 12, 2025 | 2025 (Q2) | -0.97-0.89 | -1.24 | 27.89% (+0.35) | |
| Feb 10, 2025 | 2025 (Q1) | -1.14-0.89 | -1.33 | 33.54% (+0.45) | |
| Nov 25, 2024 | 2024 (Q4) | -0.98-1.15 | -1.12 | -2.26% (-0.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

